Directly Observed Therapy Completed Phase 3 Trials for Saquinavir (DB01232)

IndicationStatusPhase
DBCOND0034188 (Directly Observed Therapy)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00285883Directly Observed Therapy in High Risk Populations in Newark, NJ